Investment
Features
FeesSafety
Academy
More
Pluang+

Michael Saylor warns Bitcoin's internal rule changes pose biggest threat, urging protocol stability and security funding.

Market News
28 Jul 2026
Crypto news
View Source
Bearish
pluang ai news

Michael Saylor, Executive Chairman of Strategy, warns that changes to Bitcoin's consensus rules represent the greatest long-term threat to the cryptocurrency, surpassing risks from rivals or governments. He argues that these rules protect Bitcoin's core features like property rights, scarcity, and transaction settlement, and that altering them could lead to internal conflicts, reduced security, and diminished miner incentives. Saylor opposes proposals like BIP-110 and others that could weaken block-space scarcity or complicate the protocol, advocating instead for a simple, neutral, and secure base layer with new features built on second layers. Strategy and eight other firms have pledged $15 million over three years to support Bitcoin security research, emphasizing cautious upgrades and corporate adoption as key to Bitcoin's future growth and resilience.

More News

AGC Biologics secures multi-year, multi-million dollar commercial production deal for new Yokohama biopharma site.

AGC Biologics secures multi-year, multi-million dollar commercial production deal for new Yokohama biopharma site.

AGC Biologics has signed a multi-year commercial manufacturing agreement with a major pharmaceutical company for its new Yokohama facility, locking in half of the mammalian cell production capacity. The deal, worth hundreds of millions of dollars, co...

Company Fundamentals
Bullish
4 hours ago
AGC Biologics secures multi-year commercial manufacturing deal worth hundreds of millions for new Yokohama site.

AGC Biologics secures multi-year commercial manufacturing deal worth hundreds of millions for new Yokohama site.

AGC Biologics has signed a multi-year commercial manufacturing contract valued at hundreds of millions of dollars with a major biopharma company for its new Yokohama facility. The contract covers production of five biopharmaceutical programs, securin...

Company Fundamentals
Bullish
4 hours ago
AGC Biologics signs multi-year commercial production deal worth hundreds of millions for new Yokohama facility.

AGC Biologics signs multi-year commercial production deal worth hundreds of millions for new Yokohama facility.

AGC Biologics has secured a long-term commercial manufacturing contract with a global biopharma company for its new Yokohama facility, expected to generate hundreds of millions of dollars. The contract covers production of five biopharmaceutical prod...

Company Fundamentals
Bullish
4 hours ago
Seagate surges on Q4 earnings beat and AI-driven data storage demand

Seagate surges on Q4 earnings beat and AI-driven data storage demand

Seagate Technology reported strong Q4 2026 results, beating earnings per share estimates with $5.71 and revenue of $3.63 billion, driven by high demand for data storage from the AI sector. The company showed solid financial health with a low debt-to-...

Company Fundamentals
Bullish
6 hours ago
Audiera (BEAT) drops 24%, breaks $3 support amid heavy selling pressure and market outflows.

Audiera (BEAT) drops 24%, breaks $3 support amid heavy selling pressure and market outflows.

Audiera (BEAT) fell sharply by 24.29%, breaking below the $3 support level to a low of $2.4 before slightly recovering to around $2.76. The drop followed increased selling pressure with significant outflows in both futures and spot markets, indicatin...

Technical Signals
Bearish
6 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App